Shares of PURE Bioscience (OTCMKTS:PURE – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.06 and traded as high as $0.07. PURE Bioscience shares last traded at $0.07, with a volume of 600 shares traded.
PURE Bioscience Price Performance
The stock’s 50-day simple moving average is $0.07 and its 200 day simple moving average is $0.06. The stock has a market capitalization of $9.10 million, a P/E ratio of -2.33 and a beta of 0.16.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last released its quarterly earnings data on Monday, March 16th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.44 million for the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Featured Articles
- Five stocks we like better than PURE Bioscience
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
